Citation Impact
Citing Papers
The principal results of the International Immune Tolerance Study: a randomized dose comparison
2011
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
Cytokines in inflammatory bowel disease
2014 Standout
Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial
2006 Standout
Emerging and receding risks of therapeutic regimens for haemophilia
2004
Semisynthetic Src SH2 Domains Demonstrate Altered Phosphopeptide Specificity Induced by Incorporation of Unnatural Lysine Derivatives
2010 StandoutNobel
Effects of Agents, Used to Treat Bleeding Disorders, on Bleeding Time Prolonged by a Very High Dose of a Direct Thrombin Inhibitor in Anesthesized Rats and Rabbits
2001
Non‐genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report
2010
Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
2010 Standout
Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation
2010 Standout
The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation
2006
International workshop on immune tolerance induction: consensus recommendations1
2007
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendations
2009
Recommendations for assessment, monitoring and follow‐up of patients with haemophilia
2011
The epidemiology of inhibitors in haemophilia A: a systematic review
2003
Immunomodulation of Autoimmune and Inflammatory Diseases with Intravenous Immune Globulin
2001
Safety and Efficacy of Recombinant Human α-Galactosidase A Replacement Therapy in Fabry's Disease
2001 Standout
Intensive exposure to factor VIII is a risk factor for inhibitor development in mild hemophilia A
2003
Human and mouse proteases: a comparative genomic approach
2003
Polymer conjugates as anticancer nanomedicines
2006 Standout
Extracellular matrix structure
2015 Standout
Home management of haemophilia
2004
Initial sequence of the chimpanzee genome and comparison with the human genome
2005 StandoutNature
Immune tolerance induction in haemophilia: evidence and the way forward
2011
Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn’s disease
2004
Recombinant Factor VIII for the Treatment of Previously Untreated Patients with Hemophilia A -- Safety, Efficacy, and Development of Inhibitors
1993
How were new medicines discovered?
2011 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Strategies in the design of nanoparticles for therapeutic applications
2010 Standout
Designing hydrogels for controlled drug delivery
2016 Standout
mRNA transcript therapy
2014 StandoutNobel
Mice carrying a knock-in mutation of Aicda resulting in a defect in somatic hypermutation have impaired gut homeostasis and compromised mucosal defense
2011 StandoutNobel
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Management of acute haemarthrosis in haemophilia A without inhibitors: literature review, European survey and recommendations
2011
Idarucizumab for Dabigatran Reversal
2015 Standout
Ulcerative colitis
2020 Standout
The effects of proton radiation on the prothrombin and partial thromboplastin times of irradiated ferrets
2012
Clinical Utility of Measuring Infliximab and Human Anti-Chimeric Antibody Concentrations in Patients With Inflammatory Bowel Disease
2010
Surgery and inhibitor development in hemophilia A: a systematic review
2011
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Cardiac surgery in patients with haemophilia B: a case report and review of the literature
2009
Management of Crohn's Disease in Adults
2009 Standout
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
IgG Subclasses and Allotypes: From Structure to Effector Functions
2014 Standout
The dawning era of polymer therapeutics
2003 Standout
Interspecies scaling and prediction of human clearance: comparison of small- and macro-molecule drugs
2011
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
2005 Standout
Hydrogen Peroxide: A Signaling Messenger
2006 Standout
Acute effects of solar particle event radiation
2014 StandoutNobel
Intracellular Protein Delivery System with Protein Needle–GFP Construct
2014 StandoutNobel
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
Leucovorin plus 5-fluorouracil: an effective treatment for metastatic colon cancer.
1987
Review: Advances in Intraperitoneal (Intracavitary) Administration of Synthetic Polymers for Immunotherapy and Chemotherapy
1986
Clinical Science Review: The Routinization of Intraperitoneal (Intracavitary) Chemotherapy and Immunotherapy
1986
Pharmacokinetics of Coagulation Factors
2001
Preparation of Porous Polysaccharides Templated by Coordination Polymer with Three-Dimensional Nanochannels
2017 StandoutNobel
The Nijmegen Modification of the Bethesda Assay for Factor VIII:C Inhibitors: Improved Specificity and Reliability
1995
Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag
2009 StandoutNobel
Single-nanometer iron oxide nanoparticles as tissue-permeable MRI contrast agents
2021 StandoutNobel
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
Cytosolic expression, solution structures, and molecular dynamics simulation of genetically encodable disulfide‐rich de novo designed peptides
2018 StandoutNobel
The clinical significance of immunoglobulin A deficiency
2007
Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer
2003 Standout
Recombinant Factor IX Recovery and Inhibitor Safety: A Canadian Post-licensure Surveillance Study
2002
Efficacy and Safety of a 4-Factor Prothrombin Complex Concentrate in Patients on Vitamin K Antagonists Presenting With Major Bleeding
2013
Guidelines for the management of hemophilia
2012 Standout
Works of S Courter being referenced
Epitope specificity and functional characterization of factor VIII inhibitors
1995
Clinical evaluation of B-domain deleted recombinant factor VIII in previously treated patients
2001
Use of recombinant factor IX in subjects with haemophilia B undergoing surgery
2002
Long-term use of IgA-depleted intravenous immunoglobulin in immunodeficient subjects with anti-IgA antibodies
1993
A multicenter study of recombinant factor VIII (recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. The Recombinate Study Group.
1994
A multicenter study of recombinant factor VIII (Recombinate) in previously treated patients with hemophilia A. The Recombinate Previously Treated Patient Study Group.
1997
A Multicenter Study of Recombinant Factor VIII (RecombinateTM) in Previously Treated Patients with Hemophilia A
1997
Hepatic artery ligation and portal vein infusion for liver metastases from colon cancer.
1984
Clinical evaluation of recombinant factor IX.
1998
Clinical evaluation of B-domain deleted recombinant factor VIII in previously untreated patients
2001
Human recombinant factor IX: safety and efficacy studies in hemophilia B patients previously treated with plasma-derived factor IX concentrates
2001
Treatment of Hemophilia A with a Highly Purified Factor VIII Concentrate Prepared by Anti-FVIIIc Immunoaffinity Chromatography
1992